No significant strengths identified
| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| ALNYAlnylam Pharmaceuticals, Inc. | 44.07B | 332.92 | 142.88 | 65.19% | 8.45% | 39.76% | 1.06% | 3.76 |
| SLXNWSilexion Therapeutics Ltd. | 63.6M | 0.03 | 0.00 | -132.54% | ||||
| EDITEditas Medicine, Inc. | 205.18M | 2.20 | -0.76 | -58.64% | -430.84% | -14.85% | 0.26 | |
| SGMOSangamo Therapeutics, Inc. | 92.01M | 0.43 | -0.88 | -67.2% | -331.28% | -17.44% | 1.34 | |
| CAMPCAMP4 Therapeutics Corporation | 210.49M | 4.49 | -1.69 | 86.29% | -14.04% | -133.54% | 0.14 | |
| SLNSilence Therapeutics plc | 256.95M | 5.44 | -1.71 | 70.47% | -252.16% | -84.61% | 0.00 | |
| PEPGPepGen Inc. | 202.89M | 6.22 | -2.18 | -57.35% | 0.16 | |||
| ARCTArcturus Therapeutics Holdings Inc. | 224.14M | 8.23 | -2.74 | -12.27% | -72.48% | -29.71% | 0.12 |
Analyze head-to-head performance against top industry competitors across valuation, growth, and profitability metrics.
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 16.48M | 26.12M | 30.43M | 43.1M | 57.99M | 33.05M | 52.12M | 36.27M | 57.88M | 0 |
| Revenue Growth % | 172.65% | 58.49% | 16.53% | 41.63% | 34.55% | -43.01% | 57.69% | -30.4% | 59.55% | -100% |
| Cost of Goods Sold | 31.84M | 67.65M | 89.11M | 108.41M | 150.41M | 6.89M | 7.57M | 8.98M | 10.29M | 0 |
| COGS % of Revenue | 193.22% | 259.02% | 292.81% | 251.52% | 259.35% | 20.85% | 14.53% | 24.74% | 17.77% | - |
| Gross Profit | -15.36M | -41.53M | -58.68M | -65.31M | -92.41M | 26.16M | 44.55M | 27.3M | 47.59M | 0 |
| Gross Margin % | -93.22% | -159.02% | -192.81% | -151.52% | -159.35% | 79.15% | 85.47% | 75.26% | 82.23% | - |
| Gross Profit Growth % | -199.67% | -170.36% | -41.3% | -11.3% | -41.5% | 128.31% | 70.28% | -38.72% | 74.34% | -100% |
| Operating Expenses | 48.64M | 95.67M | 121.3M | 41.06M | 44.17M | 294.01M | 502.71M | 542.59M | 581.86M | 508.66M |
| OpEx % of Revenue | 295.15% | 366.32% | 398.58% | 95.26% | 76.16% | 889.52% | 964.51% | 1495.77% | 1005.33% | - |
| Selling, General & Admin | 16.8M | 28.02M | 32.19M | 41.06M | 44.17M | 71.1M | 90.31M | 116.5M | 125.83M | 119.8M |
| SG&A % of Revenue | 101.94% | 107.31% | 105.77% | 95.26% | 76.16% | 215.1% | 173.26% | 321.15% | 217.41% | - |
| Research & Development | 31.84M | 67.65M | 89.11M | 108.41M | 150.41M | 229.81M | 419.98M | 435.07M | 466.31M | 388.86M |
| R&D % of Revenue | 193.22% | 259.02% | 292.81% | 251.52% | 259.35% | 695.27% | 805.78% | 1199.36% | 805.69% | - |
| Other Operating Expenses | 0 | 0 | 0 | -108.41M | -150.41M | -6.89M | -7.57M | -8.98M | -10.29M | 0 |
| Operating Income | -32.16M | -69.56M | -90.87M | -106.37M | -136.58M | -267.85M | -458.16M | -515.29M | -534.26M | 0 |
| Operating Margin % | -195.15% | -266.32% | -298.58% | -246.78% | -235.51% | -810.37% | -879.04% | -1420.51% | -923.1% | - |
| Operating Income Growth % | -139.83% | -116.28% | -30.64% | -17.06% | -28.41% | -96.11% | -71.05% | -12.47% | -3.68% | 100% |
| EBITDA | -31.05M | -66.56M | -86.41M | -100.78M | -130.27M | -260.96M | -450.59M | -506.31M | -523.98M | 0 |
| EBITDA Margin % | -188.45% | -254.86% | -283.91% | -233.81% | -224.63% | -789.52% | -864.51% | -1395.77% | -905.33% | - |
| EBITDA Growth % | -137.41% | -114.33% | -29.81% | -16.64% | -29.26% | -100.32% | -72.67% | -12.37% | -3.49% | 100% |
| D&A (Non-Cash Add-back) | 1.1M | 2.99M | 4.46M | 5.59M | 6.31M | 6.89M | 7.57M | 8.98M | 10.29M | 0 |
| EBIT | -32.16M | -69.56M | -90.87M | -106.37M | -136.58M | -267.85M | -458.16M | -515.29M | -534.26M | 0 |
| Net Interest Income | 525K | 2.01M | 5.53M | 6.83M | 2.35M | 1.28M | 8.54M | 49.83M | 47.81M | 0 |
| Interest Income | 525K | 2.01M | 5.53M | 6.83M | 2.35M | 1.28M | 8.54M | 49.83M | 47.81M | 29.2M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 525K | 2.01M | 5.53M | 6.83M | 2.35M | -42K | -16.02M | 34.1M | 15.24M | 0 |
| Pretax Income | -31.63M | -67.54M | -85.34M | -99.53M | -134.23M | -267.89M | -474.19M | -481.19M | -519.02M | -412.69M |
| Pretax Margin % | -191.97% | -258.62% | -280.42% | -230.92% | -231.46% | -810.49% | -909.78% | -1326.51% | -896.77% | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
| Net Income | -31.63M | -67.54M | -85.34M | -99.53M | -134.23M | -267.89M | -474.19M | -481.19M | -519.02M | -412.69M |
| Net Margin % | -191.97% | -258.62% | -280.42% | -230.92% | -231.46% | -810.49% | -909.78% | -1326.51% | -896.77% | - |
| Net Income Growth % | -155.17% | -113.51% | -26.35% | -16.63% | -34.86% | -99.58% | -77.01% | -1.48% | -7.86% | 20.49% |
| Net Income (Continuing) | -31.63M | -67.54M | -85.34M | -99.53M | -134.23M | -267.89M | -474.19M | -481.19M | -519.02M | -412.69M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.91 | -1.88 | -1.98 | -1.96 | -2.40 | -3.78 | -6.16 | -5.42 | -5.25 | -3.81 |
| EPS Growth % | -30% | -106.59% | -5.32% | 1.01% | -22.45% | -57.5% | -62.96% | 12.01% | 3.14% | 27.43% |
| EPS (Basic) | -0.91 | -1.88 | -1.98 | -1.96 | -2.40 | -3.78 | -6.16 | -5.42 | -5.25 | -3.81 |
| Diluted Shares Outstanding | 34.62M | 36.01M | 43.07M | 47.25M | 55.99M | 70.89M | 76.97M | 88.77M | 98.85M | 108.38M |
| Basic Shares Outstanding | 34.62M | 36.01M | 43.07M | 47.25M | 55.99M | 70.89M | 76.97M | 88.77M | 98.85M | 108.38M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 281.31M | 354.83M | 324.98M | 289.48M | 616.52M | 769.3M | 1.22B | 998.33M | 639.86M | 527.71M |
| Cash & Short-Term Investments | 273.06M | 340.68M | 314.06M | 279.73M | 597.37M | 748.69M | 1.19B | 912.22M | 601.51M | 449.88M |
| Cash Only | 273.06M | 340.68M | 58.86M | 57.23M | 160.02M | 123.41M | 523.51M | 226.75M | 189.18M | 155.46M |
| Short-Term Investments | 0 | 0 | 255.2M | 222.5M | 437.35M | 625.28M | 669.12M | 685.48M | 412.33M | 294.42M |
| Accounts Receivable | 6.45M | 10.47M | 7.55M | 4.62M | 2.13M | 2.03M | 3.77M | 36.46M | 8.52M | 9.47M |
| Days Sales Outstanding | 142.95 | 146.34 | 90.51 | 39.12 | 13.41 | 22.43 | 26.39 | 366.82 | 53.71 | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.79M | 3.68M | 3.37M | 0 | 0 | 0 | 20.41M | 49.65M | 29.83M | 68.36M |
| Total Non-Current Assets | 17.66M | 21.41M | 22.34M | 44.8M | 59.8M | 525.16M | 303.32M | 302.65M | 551.15M | 314.42M |
| Property, Plant & Equipment | 10.63M | 15.27M | 17.06M | 37.13M | 55.06M | 100.11M | 161M | 148.13M | 246.67M | 123.63M |
| Fixed Asset Turnover | 1.55x | 1.71x | 1.78x | 1.16x | 1.05x | 0.33x | 0.32x | 0.24x | 0.23x | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 4.75M | 4.75M | 425.05M | 142.32M | 154.51M | 44.26M | 35.54M |
| Other Non-Current Assets | 7.04M | 6.13M | 5.28M | 2.92M | 0 | 0 | 0 | 0 | 260.21M | 155.25M |
| Total Assets | 298.97M | 376.24M | 347.31M | 334.28M | 676.32M | 1.29B | 1.52B | 1.3B | 1.19B | 842.13M |
| Asset Turnover | 0.06x | 0.07x | 0.09x | 0.13x | 0.09x | 0.03x | 0.03x | 0.03x | 0.05x | - |
| Asset Growth % | 263.98% | 25.84% | -7.69% | -3.75% | 102.32% | 91.4% | 17.43% | -14.42% | -8.45% | -29.29% |
| Total Current Liabilities | 30.73M | 31.36M | 40.57M | 35.63M | 64.25M | 125.83M | 126.55M | 115.21M | 110.85M | 103.88M |
| Accounts Payable | 4.65M | 2.17M | 2.71M | 3.94M | 10.46M | 9.65M | 5.15M | 7.45M | 14.59M | 20.25M |
| Days Payables Outstanding | 53.33 | 11.72 | 11.09 | 13.27 | 25.38 | 511.3 | 248.44 | 303.03 | 517.74 | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 26.48M |
| Deferred Revenue (Current) | 20.18M | 21.19M | 27.12M | 12.67M | 22.54M | 63.76M | 43.84M | 22.14M | 20.66M | 7.29M |
| Other Current Liabilities | 3.2M | 3.23M | 4.57M | 6.31M | 10.92M | 20.36M | 21.78M | 6.89M | 55.35M | 70.11M |
| Current Ratio | 9.15x | 11.32x | 8.01x | 8.12x | 9.59x | 6.11x | 9.61x | 8.67x | 5.77x | 5.08x |
| Quick Ratio | 9.15x | 11.32x | 8.01x | 8.12x | 9.59x | 6.11x | 9.61x | 8.67x | 5.77x | 5.08x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 58.4M | 44.28M | 28.82M | 28.77M | 85M | 128.39M | 157.98M | 135.6M | 208.21M | 66.85M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 66.85M |
| Capital Lease Obligations | 0 | 0 | 0 | 12.63M | 33.61M | 64.91M | 114.02M | 96.75M | 189.95M | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -38.85M | 0 | 0 |
| Other Non-Current Liabilities | 293K | 168K | 13K | 0 | 0 | 0 | 24.03M | 38.85M | 0 | 0 |
| Total Liabilities | 89.13M | 75.64M | 69.39M | 64.4M | 149.25M | 254.22M | 284.53M | 250.81M | 319.06M | 170.73M |
| Total Debt | 0 | 0 | 0 | 18.38M | 39.3M | 74.02M | 130.7M | 115.35M | 210.2M | 93.33M |
| Net Debt | -273.06M | -340.68M | -58.86M | -38.85M | -120.72M | -49.38M | -392.8M | -111.4M | 21.02M | -62.13M |
| Debt / Equity | - | - | - | 0.07x | 0.07x | 0.07x | 0.11x | 0.11x | 0.24x | 0.14x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 209.84M | 300.6M | 277.92M | 269.88M | 527.07M | 1.04B | 1.24B | 1.05B | 871.96M | 671.39M |
| Equity Growth % | 211.53% | 43.25% | -7.54% | -2.89% | 95.3% | 97.36% | 18.78% | -15.01% | -16.97% | -23% |
| Book Value per Share | 6.06 | 8.35 | 6.45 | 5.71 | 9.41 | 14.67 | 16.05 | 11.83 | 8.82 | 6.20 |
| Total Shareholders' Equity | 209.84M | 300.6M | 277.92M | 269.88M | 527.07M | 1.04B | 1.24B | 1.05B | 871.96M | 671.39M |
| Common Stock | 4K | 4K | 5K | 5K | 7K | 7K | 9K | 9K | 10K | 12K |
| Retained Earnings | -53.57M | -121.11M | -201.03M | -300.88M | -435.11M | -703M | -1.18B | -1.66B | -2.18B | -2.59B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | -28K | 261K | 1K | -2.63M | -7.46M | -2.26M | 605K | 1.03M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 36.11M | -65.28M | -61.26M | -103.24M | -49.91M | -225.03M | -333.29M | -394.09M | -348.88M | -348.88M |
| Operating CF Margin % | 219.12% | -249.94% | -201.28% | -239.52% | -86.06% | -680.82% | -639.45% | -1086.38% | -602.8% | - |
| Operating CF Growth % | 2148.16% | -280.77% | 6.16% | -68.54% | 51.65% | -350.85% | -48.11% | -18.24% | 11.47% | 0% |
| Net Income | -31.63M | -67.54M | -85.34M | -99.53M | -134.23M | -267.89M | -474.19M | -481.19M | -519.02M | -519.02M |
| Depreciation & Amortization | 1.1M | 2.99M | 4.46M | 5.59M | 6.31M | 6.89M | 7.57M | 8.98M | 10.29M | 10.29M |
| Stock-Based Compensation | 6.71M | 15.32M | 17.05M | 15.09M | 19.9M | 47.01M | 91.4M | 134.05M | 154.27M | 154.27M |
| Deferred Taxes | -6.7M | 0 | 0 | 0 | 0 | 8.93M | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 6.71M | 166K | -601K | -3.72M | 573K | 2.94M | 95.8M | -3.47M | -6.29M | 5.58M |
| Working Capital Changes | 59.91M | -16.21M | 3.18M | -20.66M | 57.53M | -22.9M | -53.87M | -52.45M | 11.88M | 0 |
| Change in Receivables | -5.45M | -4.02M | 2.92M | 2.93M | 2.49M | 99K | -1.74M | -32.69M | 27.94M | 27.94M |
| Change in Inventory | -4.39M | 1.28M | 3.96M | 1.65M | 0 | 7.82M | 0 | 0 | 0 | 0 |
| Change in Payables | 1.78M | -488K | 232K | 1.88M | 5.06M | 529K | -4.58M | 2.52M | 6.8M | 6.8M |
| Cash from Investing | -6.17M | -10.09M | -260.78M | 25.18M | -214.49M | -550.78M | 160.31M | -31.35M | 125.57M | 125.57M |
| Capital Expenditures | -6.17M | -10.09M | -6.36M | -6.79M | -3.58M | -12.76M | -58.39M | -13.98M | -5.78M | -5.78M |
| CapEx % of Revenue | 37.41% | 38.64% | 20.89% | 15.76% | 6.18% | 38.59% | 112.03% | 38.55% | 9.98% | - |
| Acquisitions | 0 | 0 | 131K | -31.97M | 0 | -3M | -44.68M | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -10.1K | 131K | 31.97M | 0 | 0 | 44.83M | 0 | 0 | 20.97M |
| Cash from Financing | 167.3M | 142.98M | 40.22M | 76.43M | 371.78M | 736.69M | 582.96M | 130.32M | 185.75M | 185.75M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -3.1M | 1.98M | 11.67M | 4.18M | 13.13M | 43.12M | 17.17M | 10.53M | 8.85M | 185.75M |
| Net Change in Cash | 197.25M | 67.61M | -281.82M | -1.63M | 107.38M | -39.12M | 409.98M | -295.11M | -37.57M | -37.57M |
| Free Cash Flow | 29.94M | -75.37M | -67.61M | -110.03M | -53.5M | -237.79M | -391.68M | -408.07M | -354.66M | -354.66M |
| FCF Margin % | 181.71% | -288.57% | -222.17% | -255.28% | -92.25% | -719.41% | -751.48% | -1124.94% | -612.78% | - |
| FCF Growth % | 793.63% | -351.69% | 10.29% | -62.74% | 51.38% | -344.48% | -64.72% | -4.19% | 13.09% | 0% |
| FCF per Share | 0.87 | -2.09 | -1.57 | -2.33 | -0.96 | -3.35 | -5.09 | -4.60 | -3.59 | -3.27 |
| FCF Conversion (FCF/Net Income) | -1.14x | 0.97x | 0.72x | 1.04x | 0.37x | 0.84x | 0.70x | 0.82x | 0.67x | 0.85x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -22.82% | -26.46% | -29.5% | -36.34% | -33.69% | -34.18% | -41.67% | -42.1% | -54% | -53.48% |
| Return on Invested Capital (ROIC) | - | - | -76.16% | -35.45% | -32.14% | -28.76% | -37.48% | -43.39% | -43.75% | - |
| Gross Margin | -93.22% | -159.02% | -192.81% | -151.52% | -159.35% | 79.15% | 85.47% | 75.26% | 82.23% | - |
| Net Margin | -191.97% | -258.62% | -280.42% | -230.92% | -231.46% | -810.49% | -909.78% | -1326.51% | -896.77% | - |
| Debt / Equity | - | - | - | 0.07x | 0.07x | 0.07x | 0.11x | 0.11x | 0.24x | 0.14x |
| FCF Conversion | -1.14x | 0.97x | 0.72x | 1.04x | 0.37x | 0.84x | 0.70x | 0.82x | 0.67x | 0.85x |
| Revenue Growth | 172.65% | 58.49% | 16.53% | 41.63% | 34.55% | -43.01% | 57.69% | -30.4% | 59.55% | -100% |
Explore detailed financial history, valuation models, and returns analysis
DCF models, peer multiples & analyst estimates
Historical returns with dividends reinvested
Yield, growth, payout safety & DRIP calculator
EPS trends, net income & profitability analysis
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of valuation, profitability & efficiency metrics